VPO-227

N/A

Report date: 2025/07/21 16:22:41
NME

Base Information

Drug NameVPO-227
Drug Alias NameBP-O27BPO27VPO-227
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCystic fibrosis transmembrane conductance regulator inhibitors
TargetsCystic fibrosis transmembrane conductance regulator
Therapy Area/IndicationsPolycystic Kidney DiseasesCholera
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesVanda Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesVanda Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsPolycystic Kidney DiseasesCholera
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A